Author

Emma C. Fink

Loyola University ChicagoORCID 0009-0002-8506-0995Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Emma C. Fink1 paper · Dana-Farber Cancer Institute;

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adam T. NelczykiD· 1 shared Amanda J. SmithiD· 1 shared Anasuya Das GuptaiD· 1 shared Claire P. SchaneiD· 1 shared Élise JacquiniD· 1 shared Erik Russell NelsoniD· 1 shared Erin WeisseriD· 1 shared Evelyn Tjoanda· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam T. NelczykORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 14, 2023

Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression

Hashni Epa Vidana Gamage, Sayyed Hamed Shahoei, Samuel T. Albright…·Erik Russell Nelson

This paper shows that NR0B2 in myeloid cells reduces Treg expansion and tumor growth by modulating the NLRP3 inflammasome, with small molecule agonists improving ICB efficacy in breast cancer.

DOI 10.1101/2023.08.14.553229

mouseexperimental assay

𝕏 PostBluesky